Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells

被引：105
作者：
Orzan, F. [1 ]
Pellegatta, S. [1 ,2 ]
Poliani, P. L. [4 ]
Pisati, F. [1 ,2 ]
Caldera, V.
Menghi, F. [6 ]
Kapetis, D. [3 ]
Marras, C. [1 ]
Schiffer, D. [5 ]
Finocchiaro, G. [1 ,2 ]
机构：
[1] Univ Milano Bicocca, Fdn IRCCS, Ist Neurol C Besta, I-20133 Milan, Italy
[2] Univ Milano Bicocca, IFOM IEO Campus, I-20133 Milan, Italy
[3] Univ Milano Bicocca, Genopolis Consortium Funct Gen, I-20133 Milan, Italy
[4] Univ Brescia, Brescia, Italy
[5] Ctr Ric Neurobiooncol, Vercelli, Italy
[6] NHS Trust, Great Ormond St Hosp Children, London, England
来源：
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | 2011年 / 37卷 / 04期
关键词：
CD133; EZH2; glioblastoma; glioma stem-like cells; HDAC; Polycomb; SUBEROYLANILIDE HYDROXAMIC ACID; GENE-EXPRESSION; IN-VITRO; CANCER; DIFFERENTIATION; INHIBITORS; GROWTH; TUMORS; SAHA; VIVO;
D O I：
10.1111/j.1365-2990.2010.01132.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Aims: Proteins of the Polycomb repressive complex 2 (PRC2) are epigenetic gene silencers and are involved in tumour development. Their oncogenic function might be associated with their role in stem cell maintenance. The histone methyltransferase Enhancer of Zeste 2 (EZH2) is a key member of PRC2 function: we have investigated its expression and function in gliomas. Methods:EZH2 expression was studied in grade II-IV gliomas and in glioma stem-like cells (GSC) by quantitative PCR and immunohistochemistry. Effects of EZH2 down-regulation were analysed by treating GSC with the histone deacetylase (HDAC) inhibitor suberoylanide hydroxamic acid (SAHA) and by shRNA. Results: DNA microarray analysis showed that EZH2 is highly expressed in murine and human GSC. Real-time PCR on gliomas of different grade (n = 66) indicated that EZH2 is more expressed in glioblastoma multiforme (GBM) than in low-grade gliomas (P = 0.0013). This was confirmed by immunohistochemistry on an independent set of 106 gliomas. Treatment with SAHA caused significant up-regulation of PRC2 predicted target genes, GSC disruption and decreased expression of EZH2 and of the stem cell marker CD133. Inhibition of EZH2 expression by shRNA was associated with a significant decrease of glioma proliferation. Conclusion: The data suggest that EZH2 plays a role in glioma progression and encourage the therapeutic targeting of these malignancies by HDAC inhibitors.
引用
收藏
页码：381 / 394
页数：14
相关论文
共 34 条
  • [1] UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
    Agger, Karl
    Cloos, Paul A. C.
    Christensen, Jesper
    Pasini, Diego
    Rose, Simon
    Rappsilber, Juri
    Issaeva, Irina
    Canaani, Eli
    Salcini, Anna Elisabetta
    Helin, Kristian
    [J]. NATURE, 2007, 449 (7163) : 731 - U10
  • [2] Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture
    An, Zhihua
    Gluck, Christian B.
    Choy, Megan L.
    Kaufman, Laura J.
    [J]. CANCER LETTERS, 2010, 292 (02) : 215 - 227
  • [3] EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
    Bachmann, IM
    Halvorsen, OJ
    Collett, K
    Stefansson, IM
    Straume, O
    Haukaas, SA
    Salvesen, HB
    Otte, AP
    Akslen, LA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) : 268 - 273
  • [4] An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
    Ben-Porath, Ittai
    Thomson, Matthew W.
    Carey, Vincent J.
    Ge, Ruping
    Bell, George W.
    Regev, Aviv
    Weinberg, Robert A.
    [J]. NATURE GENETICS, 2008, 40 (05) : 499 - 507
  • [5] A bivalent chromatin structure marks key developmental genes in embryonic stem cells
    Bernstein, BE
    Mikkelsen, TS
    Xie, XH
    Kamal, M
    Huebert, DJ
    Cuff, J
    Fry, B
    Meissner, A
    Wernig, M
    Plath, K
    Jaenisch, R
    Wagschal, A
    Feil, R
    Schreiber, SL
    Lander, ES
    [J]. CELL, 2006, 125 (02) : 315 - 326
  • [6] Bmi1 controls tumor development in an ink4a/Arf-independent manner in a mouse model for glioma
    Bruggeman, Sophia W. M.
    Hulsman, Danielle
    Tanger, Ellen
    Buckle, Tessa
    Blom, Marleen
    Zevenhoven, John
    van Tellingen, Olaf
    van Lohuizen, Maarten
    [J]. CANCER CELL, 2007, 12 (04) : 328 - 341
  • [7] Analysis of probe level patterns in affymetrix microarray data
    Cambon, Alexander C.
    Khalyfa, Abdelnaby
    Cooper, Nigel G. F.
    Thompson, Caryn M.
    [J]. BMC BIOINFORMATICS, 2007, 8
  • [8] Role of histone H3 lysine 27 methylation in polycomb-group silencing
    Cao, R
    Wang, LJ
    Wang, HB
    Xia, L
    Erdjument-Bromage, H
    Tempst, P
    Jones, RS
    Zhang, Y
    [J]. SCIENCE, 2002, 298 (5595) : 1039 - 1043
  • [9] Cancer stem cells and glioma
    Das, Sunit
    Srikanth, Maya
    Kessler, John A.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (08): : 427 - 435
  • [10] Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo
    Eyüpoglu, IY
    Hahnen, E
    Buslei, R
    Siebzehnrübl, FA
    Savaskan, NE
    Lüders, M
    Tränkle, C
    Wick, W
    Weller, M
    Fahlbusch, R
    Blümcke, I
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) : 992 - 999
1234